The immunology of inflammatory bowel disease

Gastroenterology Clinics of North America

Volumn 31, Issue 1, 2002, Pages 77-92

  Plevy, Scott ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; CHRONIC DISEASE; ENTERITIS; ENVIRONMENTAL FACTOR; HOSTILITY; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; INFLAMMATION; PATHOGENESIS; REVIEW; EPITHELIUM CELL; HISTOLOGY; INTESTINE MUCOSA; LYMPHOCYTE; PHYSIOLOGY;

SECRETORY IMMUNOGLOBULIN;

EPITHELIAL CELLS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LYMPHOCYTES;

EID: 0035986126     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(01)00006-1     Document Type: Article

References (49)

1. Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: Current and future perspectives
2. Insights from mouse models of colitis
3. Human Peyer's patches: Lympho-epithelial relationships and characteristics of immunoglobulin-producing cells
4. A model of host-microbial interactions in an open mammalian ecosystem
5. Lymphocyte homing and homeostasis
6. The intestinal epithelial cell: Processing and presentation of antigen to the mucosal immune system
7. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
8. Intestinal intraepithelial lymphocytes
9. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12
10. Responses to self and non-self intestinal microflora in health and inflammatory bowel disease
11. Does the failure to acquire helminthic parasites predispose to Crohn's disease?
12. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
13. Expression and function of the MAdCAM-1 receptor, integrin alpha 4 beta 7, on human leukocytes
14. Oral tolerance: Mechanisms and therapeutic applications
15. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
16. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5
17. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial
18. Regulation of the mucosal epithelial barrier
19. Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo
20. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
21. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
22. Mucosal immunity and inflammation: I. mucosal dendritic cells: Their specialized role in initiating T cell responses
23. Epithelial cells as sensors for microbial infection
24. Interleukin-10-deficient mice develop chronic enterocolitis
25. The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes
26. Structure and function of the intestinal epithelial barrier in health and disease
27. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
28. A three-tiered view of the role of IgA in mucosal defense
29. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells
30. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives
31. Intestinal intraepithelial T lymphocytes: Our T cell horizons are expanding
32. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice
33. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
34. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells
35. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease
36. Cytokine regulation of T-cell function: Potential for therapeutic intervention
37. New forms of treatment for inflammatory bowel disease
38. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria
39. Pouchitis: Result of microbial imbalance?
40. Medical therapy for induction and maintenance of remission in pouchitis: A systematic review
41. Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease
42. Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis
43. Activation of nuclear factor kappa B inflammatory bowel disease
44. Oral tolerance
45. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine
46. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration
47. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response
48. Definition of a lamina propria T cell responsive state: Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway
49. Regulation of TNF expression by multiple mitogen-activated protein kinase pathways